Ensysce Biosciences Inc
NASDAQ:ENSC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Ensysce Biosciences Inc (ENSC) under the Base Case is 1.9752 USD per share.
Compared with the current market price of 0.4095 USD, the stock appears
Undervalued by 79% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Ensysce Biosciences Does
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The company is headquartered in La Jolla, California and currently employs 8 full-time employees. The company went IPO on 2017-12-01. The firm develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose.
- Headquarters
- United States of America US
- Employees
- 8
- IPO date
- Dec 1, 2017
Continue ENSC Research
Decided on Ensysce Biosciences? Get an email when ENSC reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one ENSC stock?
The intrinsic value for
Ensysce Biosciences Inc (ENSC) under the Base Case is 1.9752 USD.
Is ENSC stock undervalued or overvalued?
Compared with the current market price of 0.4095 USD, the stock appears Undervalued by 79% .